ENDRA Life Sciences Inc. (NDRA) Financials

NDRA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 7.9 million 1.6 million
March 31, 2026 3.4 million 1.7 million
Dec. 31, 2025 3.9 million 1.6 million
Sept. 30, 2025 2.0 million 1.8 million

NDRA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -946230 ?
March 31, 2026 -1.1 million 574451
Dec. 31, 2025 -4.6 million 12878
Sept. 30, 2025 -1.2 million 144722

NDRA Net Income

No data available :(

NDRA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.7 million - 429274
March 31, 2026 356462 - 461206
Dec. 31, 2025 762365 - 492352
Sept. 30, 2025 794036 - 396537

NDRA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.5 million
March 31, 2026 1.2 million
Dec. 31, 2025 787020
Sept. 30, 2025 761218

NDRA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 18670 233665 1.2 million 5813
March 31, 2026 - 776410 1.4 million 4278
Dec. 31, 2025 3.0 million 508137 1.1 million 6360
Sept. 30, 2025 - 432113 893305 45285

NDRA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 39715
Dec. 31, 2025 - 39532
Sept. 30, 2025 - 39389

NDRA

Price: $6.05

52 week price:
2.96
9.85

Earnings Per Share: -6.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 4700

Ebitda: -2.3 million

Market Capitalization: 5.7 million

Links: